IP Library Granted Patent US 9,962,352
Granted Patent B2
US 9,962,352 · App. 15/344,835 · Granted May 8, 2018

Creatine oral supplementation using creatine hydrochloride salt

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,962,352
App. No.
15/344,835
Granted
May 8, 2018
Kind
B2
Abstract

The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.

Claims (25)

1. An oral supplement comprising:

creatine HCl having an aqueous solubility of at least about 15 times greater than creatine monohydrate in water at 25° C. after a time period of about 1.5 hours.

2. The oral supplement of claim 1 , comprised in a beverage, a liquid meal replacement, a nutritional bar, or a food product.

3. The oral supplement of claim 1 , comprised in an additive or feed supplement for livestock.

4. The oral supplement of claim 1 , further comprising:

at least one flavoring agent selected from the group comprising cocoa, yogurt, peanut butter, mint, cheesecake, hazelnut paste, almonds, granola, coconut, strawberry, banana, cherry, plum, raspberry, lemon, orange, lime, pineapple, blueberry and other fruit flavors, coffee, or cremes and jellies, and combinations thereof.

5. The oral supplement of claim 1 , further comprising:

at least one additional supplement selected from the group comprising carbonate salt, methylsulfonylmethane, glucosamine, and chondroitin.

6. The oral supplement of claim 1 , further comprising:

at least one compound selected from the group comprising proteins, amino acid supplements, carbohydrates, D-Ribose, fats, fiber and combinations thereof.

7. An oral supplement comprising:

creatine HCl having a solubility of at least about 150 mg/mL in water at 25° C. after a time period of about 1.5 hours.

8. The oral supplement of claim 7 , wherein the creatine HCl is at least 95 percent free of contaminants.

9. The oral supplement of claim 7 , comprising greater than about 50 percent of creatine HCl.

10. The oral supplement of claim 7 , comprised in a liquid or feed additive.

11. The oral supplement of claim 7 , comprised in a pill, capsule, tablet, or liquid.

12. A supplement comprising granules for consumption by an animal, wherein the granules comprise creatine HCl, wherein the creatine HCl has an aqueous solubility of at least an order of magnitude higher than the aqueous solubility of creatine monohydrate.

13. The supplement of claim 12 , further comprising at least one additional supplement selected from the group comprising carbonate salts, methylsulfonylmethane, glucosamine, and chondroitin.

14. The supplement of claim 12 , further comprising at least one compound selected from the group comprising proteins, amino acid supplements, carbohydrates, D-Ribose, fats, fiber and combinations thereof.

15. The supplement of claim 12 , further comprising at least one flavoring agent.

16. The supplement of claim 12 , comprised in an additive or feed supplement for livestock.

17. The supplement of claim 12 , comprised in a beverage, a liquid meal replacement, a nutritional bar, or a food product.

18. The supplement of claim 12 , wherein the creatine HCl has an aqueous solubility of at least 600 mg/ml in water at 25° C. after a time period of about 1.5 hours.

19. The supplement of claim 12 , wherein the granules consist essentially of creatine HCl.

20. The supplement of claim 12 , wherein the granules are at least 95 percent free of contaminants.

Assignments (3)
SECURITY INTEREST Recorded Aug 21, 2020
From: VIREO SYSTEMS, INC.; FAULKNER, MARK C
To: FIRSTBANK
Reel/Frame 053579/0498 →
PATENT OWNERSHIP Recorded Nov 10, 2016
From: FAULKNER, MARK C.
To: VIREO SYSTEMS, INC.
Reel/Frame 040582/0298 →
PATENT OWNERSHIP Recorded Nov 10, 2016
From: MILLER, DONALD W.; VENNERSTROM, JONATHAN L.
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 040582/0327 →